Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Perspectives] Paying for performance: money, motivation, and uncertainty

Mr Watson, a new patient in my practice, sat on the examination table, clutching his hands. He studied the floor without speaking, rubbing his knuckles for a while before finally looking up. “So, are you advising against the PSA test because of the cost?”, he said. It was when I had finished his physical examination that Mr Watson had asked if I would do a prostate-specific antigen (PSA) test, something his previous primary care physician had done as yearly screening. I told him that, on the basis of his age, risk profile, absence of symptoms, and the risks versus benefits of testing, I did not think it was necessary.